Cancer and Hematology Center
Palliative Care Program (Cancer and Hematology)
Developmental Therapeutics Phase I Clinic
Texas Medical Center
sberg@texaschildrens.org
Address
1102 Bates Ave., Ste. 1550.06
Houston, TX 77030
Stacey L. Berg, MD
Director, Developmental Therapeutics Program
Associate Dean for Research Assurances, Baylor College of Medicine
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| NIH/NCI | fellowship | Pediatric Hematology-Oncology | 1994 |
| University of Pittsburgh School of Medicine | residency | Pediatrics | 1988 |
| University of Pittsburgh School of Medicine | internship | Pediatrics | 1986 |
| University of Pittsburgh School of Medicine | medical school | Doctor of Medicine | 1985 |
| Harvard University | bachelors | Bachelor of Arts | 1981 |
About
Dr. Stacey Berg is a pediatric oncologist specializing in the development of new anticancer drugs for children. She also has a strong interest in clinical trial design, biomedical ethics, and the incorporation of palliative care principles into pediatric oncology practice.
Board Certifications
American Board of Pediatrics
American Board of Pediatrics, Pediatric Hematology and Oncology
American Board of Pediatrics, Hospice and Palliative Medicine
Journal Participation
Reviewer, AAPS Journal
Reviewer, Biochemical Pharmacology
Reviewer, Blood
Reviewer, Bone Marrow Transplantation
Reviewer, Cancer
Reviewer, Cancer Chemotherapy and Pharmacology
Reviewer, Cancer Research
Reviewer, Cell Death and Differentiation
Reviewer, Clinical Cancer Research
Reviewer, Comparative Medicine
Reviewer, European Journal of Cancer
Reviewer, Investigational New Drugs
Reviewer, Journal of Clinical Oncology
Reviewer, Journal of the National Cancer Institute
Reviewer, Journal of Pediatric Hematology/Oncology
Reviewer, New England Journal of Medicine
Reviewer, Journal of the National Cancer Institute
Elected Positions
Leadership, Regulatory Leader, Pediatric Early Phase Clinical Trials Network Steering Committee
Member, Pediatric Early Phase Clinical Trials Network Agent Prioritization Committee
Organization
| Organization Name | Role |
|---|---|
| American Academy of Hospice and Palliative Medicine | Member |
| American Academy of Pediatrics (AAP) | Member |
| American Association for Cancer Research (AACR) | Member |
| American Pediatric Society | Member |
| American Society Clinical Oncology (ASCO) | Member |
| Children's Oncology Group (COG) | Developmental Therapeutics Steering Committee |
Research Statement
Dr. Stacey Berg’s primary research interest is in the design and conduct of early phase clinical trials of new anticancer agents. This process includes the evaluation of new agents against pediatric cancer targets in the laboratory, as well as preclinical pharmacokinetic studies. With these data, phase 1 studies are designed to determine the appropriate dose and schedule of new agents for use in children, as well as to obtain preliminary indications of activity. These results form the basis of subsequent larger scale clinical trials.
Selected Publications
Awards
2015 Center for Medical Ethics and Health Policy Faculty Service Award, Baylor College of Medicine
2011 Highest Rated Lecture, ASCO/AACR Methods in Clinical Cancer Research Workshop
Language
Latest Videos
Medically Speaking: Cancer Clinical Trials, Stacey L. Berg, MD
Relapse & Developmental Therapeutics
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.